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Introduction / objectives
Mass vaccination campaign conducted according to the
priority groups, and provision of free rapid influenza
diagnostic tests (RIDTs) and antivirals to predefined
population at flu clinics, were implemented as a national
program in Taiwan to reduce the impacts of the pan-
demic H1N1 2009 (pH1N1) influenza. This multi-center
study aimed to evaluate the effectiveness of these phar-
maceutical interventions based on hospital-wide influ-
enza surveillance data.
Methods
From 15 Aug 2009 through 1 March 2010, all in- and
outpatients who received RIDTs at 3 teaching hospitals
located in the northern, middle, and southern Taiwan,
respectively were analyzed. A time-series analysis was
conducted to estimate the effects of various pharmaceu-
tical strategies on the number of patients with positive
RIDTs each day. The daily mean level of population
immunity was estimated based on the nationwide vacci-
nation coverage rate, seroconversion rate in different
age groups and simulated time-lag for seroconversion.
Results
A total of 7,206 out of 34,359 patients had positive
RIDT results for influenza A. The greatest number of
daily positive cases in each hospital ranged from 40 to
56, and there were slight regional differences regarding
the profile of daily positive rates. Multivariate analysis of
the data from the largest hospital showed that establish-
ment of flu clinics averagely reduce 7 daily cases (p <
0.001), and an increment of 10% daily mean level of
population immunity against pH1N1 through vaccina-
tion averagely reduce 5 daily cases (p < 0.001). Similar
results were obtained in the other two hospitals.
Conclusion
Pharmaceutical strategies implemented in Taiwan were
effective in lowering the burden of pH1N1 influenza.
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